Research location
Johnson City
New York, United States
Advertisement
Research activity in Johnson City
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 71 trials and 72 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Johnson City
71 linked trials · page 1 of 2Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT05089734 · 2021-11-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)NCT04895358 · 2021-06-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)NCT04622007 · 2021-06-02 · 1 site observation
UNKNOWN
Breast Cancer Index (BCI) RegistryNCT04875351 · 2021-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)NCT04623775 · 2021-02-17 · 1 site observation
COMPLETED
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)NCT04519658 · 2020-10-12 · 1 site observation
COMPLETED
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast CancerNCT03988114 · 2019-09-16 · 1 site observation
WITHDRAWN
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerNCT03906071 · 2019-07-15 · 1 site observation
TERMINATED
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)NCT03829319 · 2019-03-25 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1NCT03743051 · 2019-03-05 · 1 site observation
COMPLETED
Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung CancerNCT03382912 · 2018-03-22 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03NCT03420781 · 2018-01-24 · 1 site observation
TERMINATED
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCNCT03326674 · 2017-12-21 · 1 site observation
TERMINATED
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboNCT03281954 · 2017-12-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01NCT03285308 · 2017-09-29 · 1 site observation
TERMINATED
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLCNCT03215706 · 2017-08-24 · 1 site observation
COMPLETED
Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung CancerNCT03090737 · 2017-06-02 · 1 site observation
COMPLETED
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart FailureNCT03035474 · 2017-04-21 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)NCT03036488 · 2017-03-07 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 WeeksNCT02713867 · 2016-05-24 · 1 site observation
COMPLETED
Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.NCT02554890 · 2016-04-29 · 1 site observation
COMPLETED
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)NCT02574078 · 2015-11-23 · 1 site observation
COMPLETED
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung CancerNCT02481830 · 2015-09-14 · 1 site observation
COMPLETED
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)NCT02294058 · 2014-12-03 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT02257736 · 2014-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung CancerNCT02152631 · 2014-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)NCT02187783 · 2014-08-25 · 1 site observation
COMPLETED
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyNCT02151149 · 2014-06-09 · 1 site observation
COMPLETED
A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast CancerNCT02120417 · 2014-05-01 · 1 site observation
TERMINATED
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy RegimenNCT02066636 · 2014-04-09 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerNCT01698918 · 2013-03-07 · 1 site observation
COMPLETED
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic NeuropathyNCT01770964 · 2012-12-01 · 1 site observation
UNKNOWN
NOLAN: Naproxen or Loratadine and NeulastaNCT01712009 · 2012-11-01 · 1 site observation
COMPLETED
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple SclerosisNCT01743651 · 2012-11-01 · 1 site observation
COMPLETED
Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®NCT01696058 · 2012-09-01 · 1 site observation
COMPLETED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldNCT01462344 · 2011-11-17 · 1 site observation
COMPLETED
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerNCT01427933 · 2011-11-01 · 1 site observation
COMPLETED
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyNCT01381874 · 2011-08-24 · 1 site observation
COMPLETED
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying TherapiesNCT01442194 · 2011-08-01 · 1 site observation
COMPLETED
Antihypertensive Treatment of Acute Cerebral Hemorrhage-IINCT01176565 · 2011-05-15 · 1 site observation
TERMINATED
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerNCT01362400 · 2011-05-01 · 1 site observation
COMPLETED
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsNCT01255761 · 2010-11-01 · 1 site observation
COMPLETED
Multi-Institutional Registry for Prostate Cancer RadiosurgeryNCT01226004 · 2010-07-01 · 1 site observation
UNKNOWN
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal InsufficiencyNCT00709865 · 2008-07-31 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.